Conversion Therapy to Everolimus in Renal Transplant Recipients: Results After One Year

Pascual, 2006, Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions, Transplant Rev, 20, 1, 10.1016/j.trre.2005.10.005 Dunn, 2006, Everolimus, Drugs, 66, 547, 10.2165/00003495-200666040-00009 Pohanka, 2006, Conversion to everolimus in maintenance patients-current clinical strategies, Nephrol Dial Transplant, 21, iii24, 10.1093/ndt/gfl301 Hariharan, 2000, Improved graft survival after renal transplantation in the United States, 1998 to 96, N Engl J Med, 342, 605, 10.1056/NEJM200003023420901 Morales, 2007, Conversion from a calcineurin-inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria, Transplant Proc, 39, 591, 10.1016/j.transproceed.2006.12.026 Vitko, 2004, Everolimus withh optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies, Am J Transplant, 4, 626, 10.1111/j.1600-6143.2004.00389.x Webster, 2006, Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials, Transplantation, 81, 1234, 10.1097/01.tp.0000219703.39149.85 Neumayer, 2005, Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical development, Transplantation, 79, S72, 10.1097/01.TP.0000162436.17526.0F Schena, 2005, The Sirolimus Renal Conversion Trial Study Group: A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients, Am J Transplant, 5, A1008 Mulay, 2005, Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials, Am J Transplant, 5, 1748, 10.1111/j.1600-6143.2005.00931.x